HDAC9 and type 2 diabetes mellitus: Targeting mitochondrial dynamics (such as HDAC inhibition) via promoting mitochondrial biogenesis, restoration of mitochondrial fusion/fission balance, and mitophagy intervention are potential strategies for improving insulin resistance and T2DM.